Literature DB >> 24668034

Treatment of hypertension in older persons: what is the evidence?

John E Morley1.   

Abstract

Evidence for treatment of hypertension in older people is limited to placebo-controlled studies that reduced blood pressure in persons over 60 years who had systolic blood pressure >160 mmHg. Generally, physicians measure blood pressure poorly, failing to look for white coat or masked hypertension, orthostasis, postprandial hypotension, or pseudohypertension. There is evidence that if 24-hour ambulatory blood pressures were obtained, the treatment goal should be substantially lower. Sleep apnea, pain, nocturnal hypoglycemia, drugs, excess aldosterone production, and pheochromocytoma should all be considered as causes of hypertension in older persons. Evidence supports a low-dose diuretic or an angiotensin converting enzyme inhibitor as appropriate first-line therapies in older persons.

Entities:  

Mesh:

Year:  2014        PMID: 24668034     DOI: 10.1007/s40266-014-0171-7

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  106 in total

1.  Hypertension associated with endothelin-secreting malignant hemangioendothelioma.

Authors:  K Yokokawa; H Tahara; M Kohno; K Murakawa; K Yasunari; K Nakagawa; T Hamada; S Otani; M Yanagisawa; T Takeda
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

Review 2.  Reserpine: a tragic victim of myths, marketing, and fashionable prescribing.

Authors:  H S Fraser
Journal:  Clin Pharmacol Ther       Date:  1996-10       Impact factor: 6.875

3.  Relationship of age and calcitonin gene-related peptide to postprandial hypotension.

Authors:  B J Edwards; H M Perry; F E Kaiser; J E Morley; D Kraenzle; R Stevenson; D Kreutter
Journal:  Mech Ageing Dev       Date:  1996-06-07       Impact factor: 5.432

4.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

5.  Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study.

Authors:  Donald C Haas; Gregory L Foster; F Javier Nieto; Susan Redline; Helaine E Resnick; John A Robbins; Terry Young; Thomas G Pickering
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

Review 6.  Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.

Authors:  Bernadette McGuinness; Stephen Todd; Peter Passmore; Roger Bullock
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

7.  Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation.

Authors:  Jean Woo; Jason Leung; John E Morley
Journal:  J Am Geriatr Soc       Date:  2012-08-02       Impact factor: 5.562

8.  Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project.

Authors:  Christopher J Bulpitt; Nigel Beckett; Ruth Peters; Jan A Staessen; Ji-Guang Wang; Marius Comsa; Robert H Fagard; Dan Dumitrascu; Vesselka Gergova; Riitta L Antikainen; Elizabeth Cheek; Chakravarthi Rajkumar
Journal:  Hypertension       Date:  2012-11-19       Impact factor: 10.190

9.  Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial.

Authors:  Deepa Sumukadas; Margaret Band; Suzanne Miller; Vera Cvoro; Miles Witham; Allan Struthers; Alex McConnachie; Suzanne M Lloyd; Marion McMurdo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-07       Impact factor: 6.053

10.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Authors:  Elena A B Azizan; Hanne Poulsen; Petronel Tuluc; Junhua Zhou; Michael V Clausen; Andreas Lieb; Carmela Maniero; Sumedha Garg; Elena G Bochukova; Wanfeng Zhao; Lalarukh Haris Shaikh; Cheryl A Brighton; Ada E D Teo; Anthony P Davenport; Tanja Dekkers; Bas Tops; Benno Küsters; Jiri Ceral; Giles S H Yeo; Sudeshna Guha Neogi; Ian McFarlane; Nitzan Rosenfeld; Francesco Marass; James Hadfield; Wojciech Margas; Kanchan Chaggar; Miroslav Solar; Jaap Deinum; Annette C Dolphin; I Sadaf Farooqi; Joerg Striessnig; Poul Nissen; Morris J Brown
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

View more
  1 in total

1.  Editorial: Frailty and Polypharmacy.

Authors:  Y Rolland; J E Morley
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.